Microphthalmia-Associated Transcription Factor (MITF) (Middle Region) Peptide
Quick Overview for Microphthalmia-Associated Transcription Factor (MITF) (Middle Region) Peptide (ABIN2184035)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- NSNCEKEGFY KFEEQNRAES ECPGMNTHSR ASCMQMDDVI DDIISLESSY
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MITF Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MITF (Microphthalmia-Associated Transcription Factor (MITF))
-
Background
-
MITF is a transcription factor that contains both basic helix-loop-helix and leucine zipper structural features. It regulates the differentiation and development of melanocytes retinal pigment epithelium and is also responsible for pigment cell-specific transcription of the melanogenesis enzyme genes. Heterozygous mutations in the this gene cause auditory-pigmentary syndromes, such as Waardenburg syndrome type 2 and Tietz syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: CMM8, MI, WS2, WS2A, bHLHe32
Protein Size: 357 -
Molecular Weight
- 39 kDa
-
Gene ID
- 4286
-
NCBI Accession
- NM_198178, NP_937821
Target
-